NCT03531190

Brief Summary

The purpose of the project is to investigate the effect of wound healing of a combined pre- and postoperative oral supplement, consisting of zinc, vitamin C, arginine and multivitamin, as a supplement for adequate nutrition in patients operated for head and neck cancer.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P25-P50 for not_applicable head-and-neck-cancer

Timeline
Completed

Started May 2018

Shorter than P25 for not_applicable head-and-neck-cancer

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 9, 2018

Completed
1 month until next milestone

Study Start

First participant enrolled

May 10, 2018

Completed
11 days until next milestone

First Posted

Study publicly available on registry

May 21, 2018

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2018

Completed
Last Updated

September 25, 2019

Status Verified

September 1, 2019

Enrollment Period

7 months

First QC Date

April 9, 2018

Last Update Submit

September 24, 2019

Conditions

Keywords

Head and neck cancerwound healingpre and post-surgical nutritionzinc, arginine, vitamin C, protein, oral supplements

Outcome Measures

Primary Outcomes (1)

  • POSAS-scale (The Patient and Observer Scar Assessment Scale v2.0 / EN)

    points on POSAS-questionaire (7-70)

    2 months

Secondary Outcomes (4)

  • Appearance of the scar (scale)

    2 months

  • Ultrasound scanning

    2 months

  • Biochemical measurements (micromol/l) at start and finish

    2 months

  • Size of the scar (cm)

    2 months

Other Outcomes (2)

  • Peripheral oxygen tension (partial pressure, kPa)

    2 months

  • Difficulty in swallowing (scale)

    2 months

Study Arms (2)

Nutritional supplement (Protein + MIX)

EXPERIMENTAL

Patients are given: Nutritional Supplement of protein 2-3 times a day + MIX once daily for 35 days

Dietary Supplement: Nutritional supplement (Protein + MIX)

Nutritional supplement (Protein)

ACTIVE COMPARATOR

Nutritional Supplement of protein as needed 2-3 times a day for 35 days

Dietary Supplement: Nutritional supplement (Protein)

Interventions

Protein supplement as needed + 750 mg vitamin C, 15 g. arginine, 35 mg. zinc and two multivitamin tablets, by mouth every day for 35 days.

Nutritional supplement (Protein + MIX)

Protein supplement as needed

Nutritional supplement (Protein)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Authorized/legal age (\> 18 years)
  • Patients who understand written and oral Danish, and are able to give written consent
  • Patients diagnosed with head and neck cancer, which are set for surgery
  • Patients operated on the outside of the neck

You may not qualify if:

  • Patients who do not understand, speak or write Danish
  • Not Authorized/not legal age (\<18 years)
  • Pregnant and breastfeeding women
  • Patients previously employed in the field of surgery within the last 5 years (prior years)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rigshospitalet

Copenhagen, 2100, Denmark

Location

MeSH Terms

Conditions

Head and Neck Neoplasms

Interventions

Dietary SupplementsProteins

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasms

Intervention Hierarchy (Ancestors)

FoodDiet, Food, and NutritionPhysiological PhenomenaFood and BeveragesAmino Acids, Peptides, and Proteins

Study Officials

  • Jens Rikardt R Andersen, MD,MPA

    University of Copenhagen, Department of Nutrition, Exercise and Sports

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized to intervention. Control is the present treatment in the department + protein supplementation
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

April 9, 2018

First Posted

May 21, 2018

Study Start

May 10, 2018

Primary Completion

November 30, 2018

Study Completion

November 30, 2018

Last Updated

September 25, 2019

Record last verified: 2019-09

Data Sharing

IPD Sharing
Will not share

Locations